Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $52.21 and last traded at $51.95, with a volume of 182726 shares traded. The stock had previously closed at $51.12.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada raised shares of Sandoz Group from a “hold” rating to a “moderate buy” rating in a research note on Friday, May 2nd.
Get Our Latest Stock Report on SDZNY
Sandoz Group Stock Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
- Five stocks we like better than Sandoz Group
- 5 discounted opportunities for dividend growth investors
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- Energy and Oil Stocks Explained
- 3 Stocks Getting Rare Double Upgrades From Analysts
- What Makes a Stock a Good Dividend Stock?
- This Banking Giant Just Got a $90 Price Target Upgrade
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
